Study summary

The purpose of this study is to focus on potential differences in the occurrence of new-onset Diabetes Mellitus (a glucose metabolism disorder) when two different regimens of immunosuppressive treatment are compared.

Additional Study Details

Phase
4
Product
  • Advagraf
  • Mycophenolate Mofetil
  • Simulect
  • Corticosteroids
  • Type
    Interventional
    Masking
    None (Open Label)
    Enrollment number
    1166
    Show Additional Study Details

    Study documents

    Scientific Results Summary
    Available Language(s): English
    Plain Language Summary
    Available Language(s): English

    Get more information

    Would you like more information about clinical trial sites that are recruiting participants for A study looking at Diabetes in Kidney Transplant recipients receiving Immunosuppressive regimen with or without steroids? Contact us by filling out your information to the right and we’ll respond to you.

    • A patient
    • A caregiver
    • A parent
    • A healthcare provider
    • A patient advocate
    • Algeria
    • Argentina
    • Armenia
    • Australia
    • Austria
    • Belarus
    • Belgium
    • Bosnia And Herzegovina
    • Brazil
    • Bulgaria
    • Canada
    • Chile
    • China
    • Colombia
    • Croatia
    • Czech Republic
    • Denmark
    • Dominican Republic
    • Egypt
    • Estonia
    • Finland
    • Former Serbia and Montenegro
    • France
    • Georgia
    • Germany
    • Greece
    • Guatemala
    • Hong Kong
    • Hungary
    • Iceland
    • India
    • Indonesia
    • Ireland
    • Israel
    • Italy
    • Japan
    • Jordan
    • Kazakhstan
    • Latvia
    • Lebanon
    • Lithuania
    • Macedonia
    • Malaysia
    • Mexico
    • Montenegro
    • Morocco
    • Netherlands
    • New Zealand
    • Norway
    • Panama
    • Peru
    • Philippines
    • Poland
    • Portugal
    • Puerto Rico
    • Republic of Korea
    • Republic of Moldova
    • Romania
    • Russian Federation
    • Saudi Arabia
    • Serbia
    • Singapore
    • Slovakia
    • Slovenia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Taiwan, Province of China
    • Thailand
    • Turkey
    • Ukraine
    • United Kingdom
    • United States
    • Vietnam

    By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

      Locations

      Contact Us
      Contact Us
      Withdrawn
      Kemerovo, Russian Federation, 650066
      Completed
      Vicenza, Italy, 36100
      Completed
      L'Aquila, Italy, 67010
      Completed
      Riga, Latvia, LV-1002
      Completed
      Cuernavaca, Mexico, 62448
      Completed
      Bucharest, Romania, 022328
      Completed
      Rennes, France, 35033
      Completed
      Olso, Norway, 0027
      Withdrawn
      Szczecin, Poland, 71-450
      Completed
      Goteborg, Sweden, 41345
      Completed
      Tartu, Estonia, 51014
      Completed
      Bonn, Germany, 53105
      Completed
      Kosice, Slovakia, 040 66
      Completed
      Suresnes, France, 92151
      Completed
      Moscow, Russian Federation, 115446
      Completed
      Sydney, Australia, 2050
      Withdrawn
      Moscow, Russian Federation, 123182
      Completed
      Helsinki, Finland, 02611
      Completed
      Kaiserslautern, Germany, 67655
      Completed
      Leuven, Belgium, 3000
      Completed
      Prague, Czech Republic, 140 21
      Completed
      Bruxelles, Belgium, 1200
      Completed
      Cali, Colombia, 760032
      Completed
      Halle Saale, Germany, 06120
      Completed
      Mannheim, Germany, 68167
      Completed
      Treviso, Italy, 31100
      Withdrawn
      Sao Paulo, Brazil, 04038-002
      Withdrawn
      St. Gallen, Switzerland, 9007
      Withdrawn
      Sao Paulo, Brazil, 01323-030
      Completed
      Sydney, Australia, 2145
      Completed
      Ancona, Italy, 60020
      Completed
      Stockholm, Sweden, 141 86
      Completed
      Regensburg, Germany, 93053
      Completed
      Madrid, Spain, 28041
      Completed
      Barcelona, Spain, 08035
      Completed
      Liege, Belgium, 4000
      Completed
      Bydgoszcz, Poland, 85-094
      Completed
      Seoul, Republic of Korea, 138-736
      Completed
      Moscow, Russian Federation, 129110
      Completed
      Bordeaux, France, 33076
      Withdrawn
      Mexico City, Mexico, 14080
      Completed
      Szczecin, Poland, 70-111
      Withdrawn
      Wroclaw, Poland, 50-417
      Completed
      Montpellier, France, 34295
      Completed
      Strasbourg, France, 67091
      Completed
      Saint-Petersburg, Russian Federation, 197022
      Completed
      Mexico City, Mexico, 14000
      Completed
      Essen, Germany, 45147
      Completed
      Barcelona, Spain, 08916
      Completed
      Roma, Italy, 00133
      Completed
      Milano, Italy, 20162
      Completed
      Vilnius, Lithuania, LT-08661
      Completed
      Porto, Portugal, 4099-001
      Completed
      D'Angers, France, 49033
      Withdrawn
      Berlin, Germany, 13353
      Withdrawn
      Rio de Janeiro, Brazil, 21040-030
      Completed
      Banska Bystrica, Slovakia, 975 17
      Completed
      Salerno, Italy, 84131
      Completed
      Uppsala, Sweden, 75185
      Completed
      Cite Nord, France, 42270
      Completed
      Lisboa, Portugal, 1649-035
      Completed
      Moscow, Russian Federation, 119992
      Completed
      Nizhniy Novgorod, Russian Federation, 603001
      Completed
      Sevilla, Spain, 41013
      Completed
      Nice, France, 06002
      Completed
      Hradec Kralove, Czech Republic, 50005
      Completed
      Debrecen, Hungary, 4032
      Completed
      Bratislava, Slovakia, 833 05
      Completed
      Brussels, Belgium, 1090
      Completed
      Szeged, Hungary, 6720
      Completed
      Aachen, Germany, 52074
      Completed
      Alicante, Spain, 03010
      Completed
      Rostock, Germany, 18055
      Completed
      Bologna, Italy, 40138
      Completed
      Nantes, France, 49033
      Completed
      Lasi, Romania, 700503
      Completed
      Cagliari, Italy, 09134
      Completed
      Le Puytren, France, 87042
      Withdrawn
      Kiel, Germany, 24105
      Completed
      Cordoba, Spain, 14004
      Completed
      Perth, Australia, 6001
      Completed
      Valladolid, Spain, 47011
      Withdrawn
      Krasnodar, Russian Federation, 350086
      Completed
      Omsk, Russian Federation, 644112
      Withdrawn
      Saint-Petersburg, Russian Federation, 197110
      Completed
      Paris, France, 75970
      Completed
      Bern, Switzerland, 3010
      Completed
      Santa Cruz de Tenerife, Spain, 38320
      Completed
      Brno, Czech Republic, 656 91
      Completed
      Padova, Italy, 35128
      Completed
      Saint-Petersburg, Russian Federation, 192242
      Completed
      Coimbra, Portugal, 3000-075
      Completed
      Gdansk, Poland, 80-952
      Completed
      Poznan, Poland, 60-479
      Completed
      Maastricht, Netherlands, 6229 HX
      Completed
      Moscow, Russian Federation, 129090
      Completed
      Olomouc, Czech Republic, 775 20
      Completed
      Ekaterinburg, Russian Federation, 620102
      Completed
      Düsseldorf, Germany, 40225
      Completed
      Pisa, Italy, 56124
      Completed
      Rouen, France, 76320
      Completed
      Valencia, Spain, 46009
      Completed
      Milano, Italy, 20132
      Completed
      Toledo, Spain, 45004
      Completed
      Muenchen, Germany, 81675
      Withdrawn
      Curitiba, Brazil, 80240-000
      Completed
      Madrid, Spain, 28034
      Completed
      Vol'skiy, Russian Federation, 404120
      Completed
      Warszawa, Poland, 02-006

      Frequently Asked Questions

      Are clinical trials only for people with advanced cancer?

      While some clinical trials may focus on more advanced cancers, many trials are open to patients at various stages of their cancer. Each study has rules about who can take part. For example, only patients in a certain age group or those who have a certain type of tumor may be able to join.

      Will I have to stop my current treatment to participate in a clinical trial?

      Sometimes researchers want participants to keep taking their current treatments during a clinical trial. Other times, you may need to stop your current treatments for a while. If the investigational treatment doesn't work, you can usually go back to your original treatment plan.

      Should I be worried about getting a placebo?

      In cancer clinical trials, a placebo is only used if there is no other treatment for that type of cancer. This helps compare an investigational treatment to the placebo. Placebos are rarely used in cancer trials because the best available treatment, called the “standard of care”, is usually given instead.

      Do I need a referral from my doctor to take part in a study?

      Your doctor may not know about all the opportunities for clinical trials that are available to you. Talk to your doctor or other medical provider about clinical trial information that you find. They can help you decide if a clinical trial is right for you. If you do not find any options on this website, we recommend you visit an online public registry website like clinicaltrials.gov to see a wide variety of available clinical trials.

      Explore More

      1

      What are clinical trials?

      2

      Why are Clinical Trials Important?

      3

      Why Participate in a Clinical Trial?